Journal of Proteomics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2021-10-08 146e295em76暂无昵称

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：蛋白组学;质谱
经验分享：2020-10-11 Submitted to Journal
2020-10-11 With Editor
2020-10-31 Under Review
2020-12-07 Decision in Process
2020-12-12 Minor Revision
2021-1-5 Revision Submitted to Journal
2021-1-16 Under Review
2021-4-21 Accept

54 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2021-07-07 vara

审稿速度:3.0 | 投稿命中率:75.0
经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。
03.08：投稿成功，一直with editor
04.09：写了催稿信，当即under review
05.31：revision，一个审稿人
06.18：返修
06.28:under review
06.28:当天接收

68 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2020-05-03 ILVhera

审稿8-12周，编辑说的

127 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-11-16 野比大雄

有催稿经历的大神吗？这杂志能催稿吗？

198 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-10-04 奋斗党

请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表:
想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!

LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!

379 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-09-17 野比大雄

你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表:
审稿速度较快.倾向生物学分析.刚刚接收一篇

123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇

423 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-09-17 野比大雄

你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表:
审稿速度较快.倾向生物学分析.刚刚接收一篇

123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇

346 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-09-16 野比大雄

这个杂志几个审稿人啊

410 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-07-24 123qq

审稿速度:1.0 | 投稿命中率:50.0
经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇

310 0

[GetPortalCommentsPageByObjectIdResponse(id=1058669, encodeId=0ea5105866965, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=146e295em76暂无昵称, createdTime=Fri Oct 08 17:45:01 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997186, encodeId=641999e18695, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿过程一直在这里看别人的经验，很有帮助，现在也发出来供大家参考。 03.08：投稿成功，一直with editor 04.09：写了催稿信，当即under review 05.31：revision，一个审稿人 06.18：返修 06.28:under review 06.28:当天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=43305466917, createdName=vara, createdTime=Wed Jul 07 14:32:45 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590167, encodeId=95ff59016e89, content=审稿8-12周，编辑说的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549244, encodeId=746554924418, content=有催稿经历的大神吗？这杂志能催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Thu Nov 16 12:37:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547917, encodeId=74a354e91774, content=请问你的文章情况如何?LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=LhtFantasy 2017-09-18 14:40:00 发表: 想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547310, encodeId=409954e31092, content=你好.一般有几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547296, encodeId=f74f54e296ed, content=你好.一般几个审稿人啊123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, beContent=123***2017-07-24 09:06:00 发表: 审稿速度较快.倾向生物学分析.刚刚接收一篇, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sun Sep 17 00:00:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547257, encodeId=f57e54e2570e, content=这个杂志几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Sat Sep 16 17:29:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544736, encodeId=4207544e3624, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度较快，倾向生物学分析，刚刚接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=310, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4bd2050137, createdName=123qq, createdTime=Mon Jul 24 09:06:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536582, encodeId=3f9a53658287, content=请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？ Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfba85670, createdName=zhoucp, createdTime=Wed May 10 15:01:00 CST 2017, time=2017-05-10, status=1, ipAttribution=)]

2017-05-10 zhoucp

请问哪个大神能帮我解答一下，样品重复之间的数值用什么方法可以计算它们的一致性？
Present in a table number of peptides identified, protein species, unique proteins, peptides and proteins showing differences in abundance among samples, qualitative (presence/absence) or quntitatives (up/down ccumulatd). When a peptide/protein is considered as variable? (consistency among replicates; statisitcs; ratios).Comment on coefficient of variance for the samples.

382 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务